Mark Bolding

This study shows that inhibiting HuR with SRI-42127 reduces neuroinflammation and secondary injury after TBI, improving functional outcomes in mice.

This study shows that ectopically expressed human rhodopsin does not respond to X-ray stimulation, unlike visible light, and cannot transduce X-ray signals into neural activity.

This paper shows that X-ray activation of cerium-doped LSO particles can increase synaptic activity via Channelrhodopsin-2 in hippocampal neurons.

The paper uses fMRI to study somatotopic organization in the human primary somatosensory cortex, finding group-level consistency with the homunculus model but individual variation.

This paper develops a noninvasive optogenetic system using radioluminescent particles and focused ultrasound to deliver light-sensitive proteins to brain regions without invasive procedures.

This paper demonstrates a method for noninvasive, temporally controlled drug delivery to the rat brain using focused ultrasound and MRI-visible albumin nanoclusters.

The paper identifies LITE-1 as essential for X-ray avoidance behavior in C. elegans, showing that LITE-1 mutants lack this response while GUR-3 mutants do not.